Remedies for hepatitis

Details Remedies for hepatitis Remedies for hepatitis

2007-04-17

2007-04-17

Whiteman, Brian (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

09646135

ABSTRACT:
The object of the present invention is to provide a novel medicinal agent useful in the treatment or the prevention of hepatitis.The present invention is, for example, a therapeutic or preventive agent for hepatitis characterized in that it comprises a complex of a drug carrier consisting essentially of 2-O-(2-diethylaminoethyl)-carbamoyl-1,3-O-dioleoylglycerol and a phospholipid with poly(I).poly(C).

REFERENCES:
patent: 4140761 (1979-02-01), Gerin et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5298614 (1994-03-01), Yano et al.
patent: 0685 457 (1994-02-01), None
patent: 0 685 234 (1995-12-01), None
patent: 1 029 544 (1998-10-01), None
NN Zein, Cytokines Cell Mol Ther., “Interferons in the management of viral hepatitis,” Dec. 1998,4(4):229-241, Abstract Only.
L Ferrell, Pathology, “Liver Pathology:Cirrhosis, Hepatitis, and Primary Liver Tumors,” 2000, vol. 13, No. 6, pp. 679-704.
K hirabayashi et al., Cancer Research,“Inhibition of Cancer Cell Growth by Polyinosinic-Polycytidylic Acid/Cationic Liposome Complex:A New Biological Activity,” Sep. 1999, 59, pp. 4325-4333.
RI Mahato et al., Human Gene Therapy, “Biodistribution and Gene Expression of Lipid/Plasmid Complexes after Systemic Administration,” Sep. 1998, 9: 2083-2099.
JP Wong et al., Vaccine, “Liposome-mediated immunotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC,” Mar. 1999, 17, pp. 1788-1795.
RI Magato et al., Journal of Pharmaceutical Sciences, “Physicochemical and Pharmacokinetic Characteristics of Plasmid DNA/Cationic Liposome Complexes,” Nov. 1995, vol. 84, No. 11, pp. 1267-1271.
A Mountain, Trends Biotechnol., “Gene therapy: the first decade,” Mar. 2000, vol. 18, pp. 119-128.
WF Anderson, Nature, “Human gene therapy,” Apr. 1998, vol. 392, pp. 25-30.
IM Verma et al., Nature, “Gene therapy-promises, problems and prospects,” Sep. 1997, vol. 389, pp. 239-242.
Wooley et al., American Journal of Veterinary Research, vol. 35, pp. 267-273, 1974.
Machida et al., Japan J. Microbiol. vol. 20, pp. 71-76, 1976.
Liaw, J Gastroenterol Hepatol. Oct. 1997;12(9-10):S346-53.
Desmyter et al. Texas Reports on Biology and Medicine 35:516-522, 1977.
Bever et al. Journal of Interferon Research, 5: 423-428, 1985.
Black et al. Antimicrobial agents and chemotherapy, 3:198-206, 1973.
Tytell et al. Proc. Soc. Exp. Biol. Med. 135 :917-21, 1970.
A Comparison of Negatively and Positively Charged Liposomes Containing Entrapped Polyinosinic Polycytidylic Acid For Interferon Induction in Mice; Wayne E. Magee, Martin L. Talcott, Steven X. Straub and Catherine Y. Vriend; May 26, 1976; pp. 610-618.
Database Medline ′Online! Jun. 1994 “In vivo antiviral effects of mismatched double-strandded RNA on duck hepatitis B virus.”
Banerjee, R., et al “Selective Inhibition of Hepatitis B Virus and Human Immunodefiency Virus Sequence-Promoted Gene Expression by Cotransfected Poly(I):Poly(C)”, Virology, Raven Press, New York, NY U.S. vol. 179, 1990, pp. 410-415 XP002918244.

Affiliated with

Also associated with

Rating

Remedies for hepatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Remedies for hepatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remedies for hepatitis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3779973